The pathogenic role of acetylcholine receptor α chain epitope within α146-162 in the development of experimental autoimmune myasthenia gravis in C57BL6 mice

Mohan Shenoy, Elzbieta Goluszko, Premkumar Christadoss

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

One of the dominant T cell epitopes in the acetylcholine receptor (AChR) α chain lies within the region 146-162 and has been implicated in the pathogenesis of experimental autoimmune myasthenia gravis (EAMG) in C57BL6 (B6) mice. To directly examine the pathogenic potential of α146-162 in EAMG, B6 mice were primed with AChR in complete Freunds adjuvant (CFA) and subsequently boosted twice with either α146-162 or a control peptide in CFA. Seventy percent of the mice boosted with α146-162 developed muscle weakness characteristic of EAMG, while none of the mice boosted with the control peptide showed any clinical signs of the disease. Thus, the data provided evidence for epitope within AChR α146-162 as one of the EAMG-inducing pathogenic epitopes in B6 mice.

Original languageEnglish (US)
Pages (from-to)338-343
Number of pages6
JournalClinical Immunology and Immunopathology
Volume73
Issue number3
DOIs
StatePublished - Dec 1994
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pathology and Forensic Medicine
  • Immunology

Fingerprint

Dive into the research topics of 'The pathogenic role of acetylcholine receptor α chain epitope within α146-162 in the development of experimental autoimmune myasthenia gravis in C57BL6 mice'. Together they form a unique fingerprint.

Cite this